Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore and Malaysia. It operates in Hospital Services and Specialised Services segments. The company owns and operates the Thomson Medical Centre, as well as a network of 37 clinics and centers that provide integrated medical healthcare facilities and services, such as obstetrics, gynaecology, paediatric, diagnostic imaging, pharmacy, 24-hour outpatient, laboratory, health screening, gynaecological oncology, dentistry, musculoskeletal and sports medicine, and medical aesthetics services, as well as counselling and specialised learning services for children with learning difficulties; and services provided by the fertility clinics, paediatric centres, cancer centres, cardiology centres, traditional Chinese medicine, specialist skin centre services. It also provides consumer products and services. In addition, the company operates a pre-natal and clinical diagnostic laboratory; the Thomson Hospital Kota Damansara, in Kota Damansara, Kuala Lumpur; Thomson Iskandar Medical Hub; fertility centers; and the Vantage Bay Healthcare City located in Iskandar Malaysia. Further, the company provides fertility consultancy, laboratory and embryology, research and development, and property development services. Additionally, it is involved in the information technology and computer service activities; and provision of project related services, including managing vaccination centres, COVID-19 treatment facilities, and transitional care facilities. Thomson Medical Group Limited was founded in 1979 and is based in Singapore.
Singaporean Market Performance
7D7 Days: -1.2%
3M3 Months: 9.8%
1Y1 Year: 27.1%
YTDYear to Date: 11.8%
Over the last 7 days, the market has dropped 2.7%, driven by a pullback of 2.4% in the Financials sector. As for the longer term, the market has actually risen by 21% in the last year. Looking forward, earnings are forecast to grow by 7.1% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.